164 related articles for article (PubMed ID: 35721293)
1. Functions of three ubiquitin-conjugating enzyme 2 genes in hepatocellular carcinoma diagnosis and prognosis.
Zhang CY; Yang M
World J Hepatol; 2022 May; 14(5):956-971. PubMed ID: 35721293
[TBL] [Abstract][Full Text] [Related]
2. Increased Expression of
Zou R; Xu H; Li F; Wang S; Zhu L
DNA Cell Biol; 2021 Jan; 40(1):36-60. PubMed ID: 33180631
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of ubiquitin-conjugating enzyme E2 S overexpression in hepatocellular carcinoma.
Ma Y; Li K; Li S; Liang B; Liu Q; Mo Z
Int J Biol Macromol; 2018 Nov; 119():225-231. PubMed ID: 30041036
[TBL] [Abstract][Full Text] [Related]
4. Ubiquitin-conjugating enzyme E2T knockdown suppresses hepatocellular tumorigenesis
Guo J; Wang M; Wang JP; Wu CX
World J Gastroenterol; 2019 Nov; 25(43):6386-6403. PubMed ID: 31798276
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of UBE2C expression and its potential roles and mechanisms in hepatocellular carcinoma.
Li X; Ma Z; Mei L
Aging (Albany NY); 2023 Aug; 15(15):7397-7407. PubMed ID: 37580802
[TBL] [Abstract][Full Text] [Related]
6. UBE2S and UBE2C confer a poor prognosis to breast cancer
Guo Y; Chen X; Zhang X; Hu X
Front Oncol; 2023; 13():992233. PubMed ID: 36860312
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of ubiquitin-conjugating enzyme E2T (UBE2T) predicts poor prognosis and promotes hepatocellular carcinoma progression.
Ren X; Li A; Ying E; Fang J; Li M; Yu J
Bioengineered; 2021 Dec; 12(1):1530-1542. PubMed ID: 33934686
[TBL] [Abstract][Full Text] [Related]
8. Identification of the potential therapeutic target gene UBE2C in human hepatocellular carcinoma: An investigation based on GEO and TCGA databases.
Wei Z; Liu Y; Qiao S; Li X; Li Q; Zhao J; Hu J; Wei Z; Shan A; Sun X; Xu B
Oncol Lett; 2019 Jun; 17(6):5409-5418. PubMed ID: 31186759
[TBL] [Abstract][Full Text] [Related]
9. UBE2T-regulated H2AX monoubiquitination induces hepatocellular carcinoma radioresistance by facilitating CHK1 activation.
Sun J; Zhu Z; Li W; Shen M; Cao C; Sun Q; Guo Z; Liu L; Wu D
J Exp Clin Cancer Res; 2020 Oct; 39(1):222. PubMed ID: 33087136
[TBL] [Abstract][Full Text] [Related]
10. UBE2S enhances the ubiquitination of p53 and exerts oncogenic activities in hepatocellular carcinoma.
Pan YH; Yang M; Liu LP; Wu DC; Li MY; Su SG
Biochem Biophys Res Commun; 2018 Sep; 503(2):895-902. PubMed ID: 29928880
[TBL] [Abstract][Full Text] [Related]
11. UBE2T promotes hepatocellular carcinoma cell growth via ubiquitination of p53.
Liu LP; Yang M; Peng QZ; Li MY; Zhang YS; Guo YH; Chen Y; Bao SY
Biochem Biophys Res Commun; 2017 Nov; 493(1):20-27. PubMed ID: 28935368
[TBL] [Abstract][Full Text] [Related]
12. UBE2C functions as a potential oncogene by enhancing cell proliferation, migration, invasion, and drug resistance in hepatocellular carcinoma cells.
Xiong Y; Lu J; Fang Q; Lu Y; Xie C; Wu H; Yin Z
Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30914455
[TBL] [Abstract][Full Text] [Related]
13. DNA primase subunit 1 deteriorated progression of hepatocellular carcinoma by activating AKT/mTOR signaling and UBE2C-mediated P53 ubiquitination.
Zhu M; Wu M; Bian S; Song Q; Xiao M; Huang H; You L; Zhang J; Zhang J; Cheng C; Ni W; Zheng W
Cell Biosci; 2021 Feb; 11(1):42. PubMed ID: 33622397
[TBL] [Abstract][Full Text] [Related]
14. [High expression of UBE2S promotes progression of hepatocellular carcinoma by increasing cancer cell stemness].
Chen H; Li Z; Wang M; Lu L; Tang Q; Luo L
Nan Fang Yi Ke Da Xue Xue Bao; 2024 Mar; 44(3):455-464. PubMed ID: 38597436
[TBL] [Abstract][Full Text] [Related]
15. UBE2C serves as a prognosis biomarker of uterine corpus endometrial carcinoma via promoting tumor migration and invasion.
Ma S; Chen Q; Li X; Fu J; Zhao L
Sci Rep; 2023 Oct; 13(1):16899. PubMed ID: 37803076
[TBL] [Abstract][Full Text] [Related]
16. Identification of overexpressed genes in hepatocellular carcinoma, with special reference to ubiquitin-conjugating enzyme E2C gene expression.
Ieta K; Ojima E; Tanaka F; Nakamura Y; Haraguchi N; Mimori K; Inoue H; Kuwano H; Mori M
Int J Cancer; 2007 Jul; 121(1):33-8. PubMed ID: 17354233
[TBL] [Abstract][Full Text] [Related]
17. UBE2S promotes cell chemoresistance through PTEN-AKT signaling in hepatocellular carcinoma.
Gui L; Zhang S; Xu Y; Zhang H; Zhu Y; Kong L
Cell Death Discov; 2021 Nov; 7(1):357. PubMed ID: 34785642
[TBL] [Abstract][Full Text] [Related]
18. Contributions of UBE2C and UBE2S to meiotic progression of porcine oocytes.
Fujioka YA; Onuma A; Fujii W; Sugiura K; Naito K
J Reprod Dev; 2018 Jun; 64(3):253-259. PubMed ID: 29576589
[TBL] [Abstract][Full Text] [Related]
19. Expression of ubiquitin-conjugating enzyme E2T in colorectal cancers and clinical implications.
Wu X; Liu G; Liu R; He J; Wang G; Zhang H; Liu T; Bai J; Cheng N; Qiu J
Oncol Lett; 2020 Nov; 20(5):275. PubMed ID: 33014154
[TBL] [Abstract][Full Text] [Related]
20. [Differential analysis of gene expression profiles in hepatocellular carcinoma patients with high and low levels of alpha-fetoprotein].
Wang XJ; Shen RF; Wang X; Wang YR; Xiao T
Zhonghua Zhong Liu Za Zhi; 2020 May; 42(5):396-402. PubMed ID: 32482029
[No Abstract] [Full Text] [Related]
[Next] [New Search]
